The Hematologist
En podkast av The Hematologist
150 Episoder
-
The End of Transplant for Mantle Cell Lymphoma
Publisert: 31.1.2025 -
DREAMMing of a Better Tomorrow: Belantamab-Based Triplet Therapy for Relapsed/Refractory Multiple Myeloma
Publisert: 21.12.2024 -
Haploidentical Stem Cell Transplantation Is an Acceptable Transformative Therapy for Young Adults With Sickle Cell Disease
Publisert: 27.11.2024 -
Enhancing Risk Stratification for Pediatric B-Cell Acute Lymphoblastic Leukemia: No Longer a ‘PI’ in the Sky Idea?
Publisert: 11.10.2024 -
A Leap of Faith? Elimination of Autologous Stem Cell Transplantation for Patients With Mantle Cell Lymphoma in First Remission
Publisert: 16.9.2024 -
Anticoagulation Stewardship
Publisert: 29.8.2024 -
Blood Global Hematology Editor-in-Chief Shares Vision
Publisert: 17.7.2024 -
One on One With Dr. Fred Appelbaum
Publisert: 26.6.2024 -
Genetic Switch System Suggests Targeting of Mutant JAK2 Reverses Myeloproliferative Neoplasms
Publisert: 21.6.2024 -
Venous Thromboembolism Risk Markers and Discontinuing Combined Hormonal Contraceptives
Publisert: 7.5.2024 -
Growing the Next Generation of Hematologists
Publisert: 15.4.2024 -
Women in Hematology
Publisert: 26.3.2024 -
Four Is Better Than Three: Will We Finally Agree?
Publisert: 18.3.2024 -
Toward Equity in Access for ALL
Publisert: 30.1.2024 -
The Brilliant Success of Blinatumomab for Babies With Acute Lymphoblastic Leukemia
Publisert: 29.11.2023 -
Editors-in-Chief of Two New ASH Journals Share Their Visions
Publisert: 20.10.2023 -
ASH’s Minority Recruitment Initiative Mentorship Program Offers a Win for All
Publisert: 18.9.2023 -
Results From the Blood and Marrow Transplant Trials Network: How Should We Prevent Graft-versus-host Disease in 2023?
Publisert: 1.9.2023 -
Genetic Background Influences the Growth of CHIP Clones Within the Bone Marrow, With Drs. Robert Hasserjian and Siddhartha Jaiswal
Publisert: 7.7.2023 -
Drawing New Blood Into Hematology
Publisert: 16.6.2023
The Hematologist is the member newsletter of American Society of Hematology (ASH). It is designed for the broad constituency of ASH, all working toward the ultimate goal of conquering blood diseases. The Hematologist updates readers about important developments in the field of hematology and highlights what ASH is doing for its members.
